Cigna's pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said ...

It was a ‘mutual agreement,’ Novo says in a statement. A search for Fruergaard Jørgensen’s successor is ongoing.

CVS’ pharmacy benefit manager Caremark also reached an agreement with Danish drugmaker Novo Nordisk to give its weight loss drug Wegovy preferred access on Caremark’s standard formulary ...

So that's something good to look forward to. But going back to this CVS Novo Nordisk deal, that is, of course, the talk of the day. If you've seen Lily stock, it has taken a beating because of its ...

Novo Nordisk having to scramble to do a deal this week held back by its historic bias to injectables." Khodjamirian said Novo's recent partnerships with Hims & Hers and the CVS formulary change ...

Novo Nordisk CEO Lars Jørgensen sits down for an ... the drugmaker's partnership and price goals with CVS Health (CVS), and the company's outlook on its US manufacturing position and President ...

The common theme at the maker of Wegovy and at UnitedHealth may be investors' sudden awareness of cost-cutting pressure.

U.S.-listed shares of Novo Nordisk are jumping in premarket trading Wednesday even as the Danish pharmaceutical giant lowered ...

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.

Novo Nordisk A/S NVO shares lost 2.7% on Friday after a surprising announcement regarding changes to its executive leadership and board of directors. Per the press release, Lars Fruergaard ...